the functional heterogeneity of human lymphokine-activated killer ( lak ) cells was characterized using lak effector cells generated in vivo during ril-2 therapy and separated by facs into leu 19 '' '' bright '' '' + and leu 19 '' '' dim '' '' + subsets .
C0086418
human
C1335621
ril